-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AXRBhnHecvrjvF4FfM3Y/AFYXcnQgK1W/sSQt++QAh20L6bZWL6P0sbwpYChQVSZ XmWoxEJ0AaU40ovPiCuPBg== 0001010549-10-000840.txt : 20101229 0001010549-10-000840.hdr.sgml : 20101229 20101229113219 ACCESSION NUMBER: 0001010549-10-000840 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101222 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20101229 DATE AS OF CHANGE: 20101229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHINA PHARMA HOLDINGS, INC. CENTRAL INDEX KEY: 0001106644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 731564807 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34471 FILM NUMBER: 101277357 BUSINESS ADDRESS: STREET 1: 2ND FLOOR, NO. 17, JINPAN ROAD STREET 2: HAIKOU CITY: HAINAN PROVINCE STATE: F4 ZIP: 570216 BUSINESS PHONE: 8689866811730 MAIL ADDRESS: STREET 1: 2ND FLOOR, NO. 17, JINPAN ROAD STREET 2: HAIKOU CITY: HAINAN PROVINCE STATE: F4 ZIP: 570216 FORMER COMPANY: FORMER CONFORMED NAME: TS ELECTRONICS INC DATE OF NAME CHANGE: 20030818 FORMER COMPANY: FORMER CONFORMED NAME: SOFTSTONE INC DATE OF NAME CHANGE: 20030128 FORMER COMPANY: FORMER CONFORMED NAME: SOFTSTONE INC /DE/ DATE OF NAME CHANGE: 20010808 8-K 1 cphi8k122910.htm CHINA PHARMA HOLDINGS, INC. cphi8k122910.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 22, 2010


CHINA PHARMA HOLDINGS, INC.
---------------------------------------
 (Exact name of Registrant as specified in charter)
 
Delaware
001-34471
73-1564807
(State or other jurisdiction
(Commission File No.)
(IRS Employer
of Incorporation)
  
Identification No.)
 
Second Floor, No. 17, Jinpan Road
Haikou, Hainan Province, China                  570216
(Address of principal executive offices)   (Zip Code)

Registrant's telephone number, including area code: +86 898-6681-1730

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]           Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

[ ]           Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)
 
[ ]           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange   Act   (17CFR240.14d-2(b))

[ ]           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))
 
 
 
 
 


Item 5.07.                      Submission of Matters to a Vote of Security Holders

On December 22, 2010, China Pharma Holdings, Inc. (the “Company”) held its annual shareholders meeting.  At the meeting, the only proposal submitted to a vote of the shareholders of the Company was to approve the 2010 Long-Term Incentive Plan.

The shareholders approved the 2010 Long-Term Incentive Plan. The number of votes cast for and against the proposal and the number of abstentions and broker non-votes were as follows:

For
Against
Abstain
Broker Non-Votes
24,790,592
2,469,164
72,867
-


 
 
 
 

 
 
 
 

SIGNATURES
 
            Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: December 29, 2010
 
  CHINA PHARMA HOLDINGS, INC.  
       
 
By:
/s/  Zhilin Li  
    Zhilin Li,  
    President and Chief Executive Officer   
       
 
 
                                                                   
 
 
 
 
 
 
 
 
 
 

 -----END PRIVACY-ENHANCED MESSAGE-----